Assist. Prof. Dr. Qingxiao Hong | Biomaterials | Research Excellence Award
The Affiliated Kangning Hospital of Ningbo University | China
Assist. Prof. Dr. Qingxiao Hong is an emerging interdisciplinary researcher whose work in biomaterials, medical genetics, epigenetics, and addiction medicine demonstrates a strong commitment to advancing translational biomedical science. With academic training rooted in biological sciences and specialized expertise in biochemistry and molecular biology, she has further enriched her profile through advanced international research exposure as a senior visiting scholar at the University of Cambridge. Dr. Hong’s research spans addiction neuroscience, psychiatric disorders, DNA methylation mechanisms, non-coding RNA regulation, and biomarker discovery, with particular emphasis on substance use disorders involving heroin and methamphetamine. She has led and contributed to multiple competitive research projects funded by provincial and national foundations, focusing on epigenetic regulation, neural reward circuitry, and relapse-associated molecular pathways. Her work has resulted in impactful publications in reputable international journals, showcasing significant contributions such as identifying novel methylation markers, characterizing neuroepigenetic regulatory mechanisms, and uncovering small RNA pathways relevant to relapse behavior. Dr. Hong has also made notable advancements in biomedical innovation through patented diagnostic technologies linked to methylation-based detection kits and genetic screening tools for addiction-related conditions. Her translational approach integrates molecular biology, behavioral neuroscience, and clinical relevance, enabling discoveries that can potentially inform precision diagnostics and therapeutic strategies. With active roles in professional societies and a record of collaboration across clinical and academic institutions, she continues to contribute meaningfully to the scientific community. Dr. Hong’s growing body of research reflects exceptional promise and positions her as a leading early-career scientist advancing innovative solutions at the interface of biomaterials, neurobiology, and human health.
Citations
Documents
h-index
View Google Scholar Profile View Scopus Profile
Featured Publications
Benzodiazepine Use Among Individuals with Opioid Use Disorder: A Narrative Review
– Substance Abuse and Rehabilitation, pp. 283–291, 2025
Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b
– NeuroReport, 36(18), 1037–1046, 2025
Biochemical Diagnosis in Substance and Non-substance Addiction
– Substance and Non-substance Addiction, pp. 149–178, 2025
tRF‐M2–Regulated Dopamine Receptor D2 Expression Attenuates Methamphetamine Reinstatement Behavior in Rats
– Annals of the New York Academy of Sciences, 2025
Association Between the (GT)26 Allele in the GRIN2A Promoter and Opioid Use Disorder
– Psychiatry Investigation, 22(6), 730, 2025